Literature DB >> 25355780

Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy.

Marcus Ståhlberg1, Mikael Sander2, Lars Mortensen3, Cecilia Linde3, Frieder Braunschweig3.   

Abstract

AIMS: To test the hypothesis that acute increased biventricularly (BiV) paced heart rate (pHR) results in decreased muscle sympathetic nerve activity (MSNA), and that dyssynchronous pacing (AAI) attenuates this effect, in heart failure patients receiving cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: Fourteen CRT patients (NYHA II-III, 12 males, mean EF 28 ± 14%) were recruited. Three different pHRs (50-90 b.p.m.) were randomly programmed in BiV- and AAI-pacing modes. Muscle sympathetic nerve activity (total sympathetic nerve activity/min (units) and number of bursts/100 RR) were recorded from the peroneal nerve using a microelectrode. In addition, cardiac output (CO) and mean blood pressure (mBP) were measured. With BiV pacing, the total MSNA/min was lower at 70 b.p.m. (-7 ± 21%, P = 0.18) and 90 b.p.m. (-29 ± 18%, P = 0.01) compared with at 50 b.p.m. (280 ± 180 U). Similarly, bursts/100RR decreased with increased BiV pHR. Cardiac output (3.7 L/min at 50 b.p.m., +12 ± 12% at 70 b.p.m., and +18 ± 19% at 90 b.p.m.) and mBP (78 ± 11 mmHg at 50 b.p.m., +6 ± 6% at 70 b.p.m. and +11 ± 8% at 90 b.p.m.) increased significantly at elevated pHRs in BiV-pacing mode. The effect on MSNA, CO, and mBP was less pronounced in AAImode but we found no significant differences between the pacing modes.
CONCLUSION: Increased pHR acutely reduces MSNA and improves haemodynamics in HF patients treated with CRT with no evident differences between BiV- and AAI-pacing modes. Further studies are warranted to guide the programming of basic pHR in CRT patients. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac resynchronization therapy; Haemodynamic; Heart failure; Heart rate; Muscle sympathetic nerve activity

Mesh:

Year:  2014        PMID: 25355780     DOI: 10.1093/europace/euu289

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.

Authors:  Jin Kyung Hwang; Hye Bin Gwag; Kyoung-Min Park; Young Keun On; June Soo Kim; Seung-Jung Park
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

2.  Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.

Authors:  Adam Ali Ghotbi; Mikael Sander; Lars Køber; Berit Th Philbert; Finn Gustafsson; Christoffer Hagemann; Andreas Kjær; Peter K Jacobsen
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

3.  Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.

Authors:  Jian-Shu Chen; Xiao-Wei Niu; Fen-Mei Chen; Ya-Li Yao
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.